Role of protein tyrosine phosphatase 1B in diabetes and heart disease | Prof. Mirela Delibegovic

This keynote was filmed at Metabolism Day on June 14, 2022 at the University of Copenhagen. Metabolism Day is hosted by the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR). For more information please visit: http://cbmr.ku.dk Please note the captions were AI generated and may contain errors. Prof. Mirela Delibegovic is the Dean for Industrial Engagement in Research and Knowledge Transfer at the University of Aberdeen and the Director (Diabetes) of the Aberdeen Cardiovascular and Diabetes Centre. She obtained her BSc Honours Pharmacology degree from the University of Edinburgh, PhD in Biochemistry at the University of Dundee, and her postdoctoral fellowship at Harvard University. Prof. Delibegovic sits on the Diabetes UK, DRWF and the British Heart Foundation project grants committees and her research focuses on the role of tyrosine phosphatases in regulation of insulin sensitivity, endothelial dysfunction and atherosclerosis. Prof. Delibegovic will be presenting recent work from her laboratory on the effects of PTP1B inhibitors in diabetes and atherosclerosis. Work in cell culture models, pre-clinical models of disease and patients with coronary heart disease will be discussed.